Alkemy Capital completes £1.35 million fundraise

Alkemy Capital Investments plc (LON:ALK:) (JV2:FRA) has announced that it has completed a £1.35 million fundraise. As part of this Alkemy has conditionally placed 657,711 ordinary shares at a placing price of £1.40 each to raise gross proceeds of c.£921,000, including a £10,000 participation by Alkemy director Helen Pein. Whilst legally restricted from participating directly in the Placing at this time, Paul Atherley and Sam Quinn have also agreed to contribute though the advance of unsecured, interest free loans of £430,000 in aggregate, with such amounts expected to be applied to subscribe for new shares at the Placing Price as soon as legally permissible as set out below.

The net proceeds of the Fundraise will be used to continue to advance the Company’s projects and will provide sufficient working capital for the Company over the next twelve months. The Company continues to advance discussions and negotiations with counterparties for lithium feedstock. The major shareholders of the Company have also committed to provide any additional working capital that may be required by the Company to enable it to reach this significant milestone.

The Directors of Alkemy have together contributed to the Fundraise in the amount of £440,000, with Helen Pein participating in the amount of £10,000 in the Placing. Paul Atherley and Sam Quinn have also both contributed in the amounts of £330,000 and £100,000, respectively, however they are members of a concert party under the City Code on Takeovers and Mergers (the “Takeover Code”) (which in aggregate currently holds 49.49% of the Company’s issued share capital) and therefore their direct participation in the Placing would have triggered a mandatory offer for the Company under Rule 9 of the Takeover Code. As such, Mr Atherley has agreed that an amount of £330,000 currently owing to him by the Company shall be treated as an advance in the form of an unsecured, interest free loan and Mr Quinn has agreed to advance the Company £100,000 in the form of an unsecured, interest free loan. The Company has agreed with Mr Atherley and Mr Quinn that the amounts to be repaid to them under such loans should be applied for the subscription of 235,714 new ordinary shares in the case of Mr Atherley and 71,428 new ordinary shares in the case of Mr Quinn, in each case at the Placing Price, with these subscriptions expected to take place at the earliest possible time permissible, which is envisaged to be in or around August 2023. At such time it is intended that the Company would apply for admission of the 307,142 new ordinary shares to listing on the Official List and to trading on the Main Market. This would not apply if and to the extent that (i) the issue of such shares would trigger a mandatory offer for the Company under the Takeover Code, (ii) the Company would not have sufficient shareholder authorities to issue such shares, or (iii) the application for admission of such new shares would require the Company to publish a prospectus.

In order to satisfy its obligations under the Placing through the issue of new ordinary shares, the Company would need to seek further shareholder authorities and publish a prospectus. Any prospectus published by the Company would need to be approved by the FCA in the United Kingdom. The Board believes that seeking further shareholder authorities and preparing a prospectus would be disproportionately costly and time-consuming.

The Placing Shares are therefore to be loaned to the Company by Mr Atherley, Chairman of the Company, in order that the Company is able to undertake the Placing in a timely manner. The Company and Paul Atherley have entered into a customary stock lending agreement dated 31 May 2023 (the “Stock Lending Agreement”) to document this arrangement. Under the Stock Lending Agreement, in repayment of the stock loan, the Company is required to deliver or procure the delivery of 657,711 ordinary shares to Paul Atherley by no later than 31 December 2023. Subject to the Company’s shareholders passing relevant resolutions to authorise the Board to allot new ordinary shares and disapply pre-emption rights at the Company’s next annual general meeting, which is expected to be held in or around July 2023, in repayment of the loan the Company intends to issue 657,711 new ordinary shares (the “Stock Loan Repayment Shares”) to Paul Atherley in or around August 2023.

The Company shall apply for admission of the Stock Loan Repayment Shares to listing on the Official List and to trading on the Main Market when they are issued, however at such point an approved prospectus is not expected to be required. As the Stock Loan Repayment Shares will be issued to Paul Atherley in accordance with the Stock Lending Agreement, this will not trigger a mandatory offer for the Company under Rule 9 of the Takeover Code.

For the avoidance of doubt, the loan of the Placing Shares to Alkemy Capital involves no cash consideration being paid to Paul Atherley in consideration for him entering into the Stock Lending Agreement and nor will any interest be payable under the Stock Lending Agreement.

Paul Atherley is a Director and is therefore is a related party of the Company. Owing to its size, the Stock Lending Agreement is considered to be a material related party transaction for the purposes of paragraph 7.3 of the FCA’s Disclosure Guidance and Transparency Rules. The Board of Directors (excluding Paul Atherley) has approved the entry by the Company into the Stock Lending Agreement and considers that the terms and conditions of the Stock Lending Agreement are fair and reasonable, insofar as the shareholders of the Company are concerned.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Share on facebook
Share on twitter
Share on linkedin
Alkemy Capital Investments plc

More articles like this

Alkemy Capital Investments plc

Alkemy Capital Investments secures joint funding package

Alkemy Capital Investments plc (LON:ALK) (FRA:JV2) and its wholly-owned subsidiary Tees Valley Lithium have announced that TVL together with Weardale Lithium has secured a joint funding package of approximately £613,000, which includes a grant of approximately £430,000 from Innovate UK.

Alkemy Capital Investments plc

Powering up the UK battery industry

The Faraday Institution estimates the UK will require 80GWh of battery production by 2030 to sustainpre-pandemic levels of car manufacturing.33 Our calculations suggest that, in a scenario where lithium-ion batteries remain the dominant battery chemistry, this will require

Alkemy Capital Investments plc

The ‘white gold’ rush for lithium

Lithium is an indispensable element in the clean energy transition for several key reasons; like all alkaline metals on the periodic table, it has one more electron than it strictly needs, and this tendency to shed electrons makes

Alkemy Capital Investments plc

UK to cut red tape for electric car batteries

Britain’s hopes of becoming an electric car production hub have received a boost after safety officials used Brexit freedoms to cut red tape around battery production. In a note to industry, the Health and Safety Executive (HSE) said

Alkemy Capital Investments plc

Speech to the Australian-British Chamber of Commerce

I would like to begin today by acknowledging the Traditional Custodians of the land on which this event is taking place, the Whadjuk Nyoongar people, and pay my respects to their Elders past and present.  I extend that

Alkemy Capital Investments plc

Is now a good time to buy lithium stocks?

After hitting all-time highs in 2022, lithium took a downward turn from November to May, when prices started to rebound. With prices now retreating again, many investors are wondering if it’s still a good time to buy lithium

Alkemy Capital Investments plc

Commodity spotlight – Lithium

The surge in lithium prices from 2021 to 2022 saw lithium stocks generate spectacular gains, often regardless of risk, project quality or profit-potential. This period was utopia for many generalist investors, because finding a new, well-marketed lithium stock

Alkemy Capital Investments plc

Alkemy joins Wave International on Western Australia site visit

Wave International, one of Australia’s leading lithium refining engineers, hosted Alkemy Capital Investments plc (LON:ALK) on a visit to Western Australia recently, as part of the studies for Australia’s first stand-alone Lithium Sulphate refinery to be located at the Boodarie Strategic Industrial Area, just outside Port Hedland,

Alkemy Capital Investments plc

The promise of all-solid-state lithium-ion batteries

In the pursuit of clean energy and carbon neutrality, all-solid-state lithium-ion batteries (ASS-LIBs) have emerged as a highly promising solution. These batteries hold potential for use in electric vehicles, neuromorphic devices, and more. However, their commercial deployment is

Alkemy Capital Investments plc

Australia to break China’s lithium grip

Slightly more than half of the world’s supply of lithium is currently mined Down Under, but handing the lion’s share of the mineral over to only one country for processing into battery materials is a key reason lithium

Alkemy Capital Investments plc

Lithium performed positively in H1

The second half of 2023 has officially begun, meaning it’s time for us to reflect on the commodities market so far this year. In the first half of the year, lithium increased by 10.81%, making it the best-performing

No more posts to show